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The adenoma–carcinoma sequence (Morson et al, 1968; Muto
et al, 1975) in colorectal tumorigenesis has been widely accepted,
and polypoid adenomas are recognized as the most likely
precursor of colorectal carcinomas. A model of genetic alterations
in the adenoma–carcinoma sequence has been proposed
(Vogelstein et al, 1988). In this model, APC mutations occur at the
initial step in adenoma formation (Powell et al, 1992), followed
by point mutations of the K-ras gene, paralleling increases in
adenoma size and grade of atypia, as well as mutations of various
other tumour suppressor genes which accumulate during tumour
development. APC mutations are found in more than 80% of
sporadic colorectal adenomas and carcinomas (Kinzler et al,
1996), suggesting that APC acts as the ‘gatekeeper’ of colonic
epithelial cell proliferation and that inactivation of this gene is
required for net cellular proliferation. K-ras gene mutations have
been found in nearly 50% of polypoid adenomas larger than 1 cm
in diameter (Vogelstein et al, 1988).
Yamagata et al reported that the frequency of K-ras mutation in
superficial adenomas was significantly lower than that in polypoid
ademomas (Yamagata et al, 1994) and that non-polypoid type
growth of submucosally invasive carcinomas (sm carcinomas) was
associated with a lower frequency of K-ras mutation than the
polypoid type (Yamagata et al, 1995), indicating carcinogenesis
through superficial adenomas to be different from that occurring
via polypoid adenomas with regard to genetic alterations.
Therefore, it was suggested that there may be a pathway different
from the conventional adenoma–carcinoma sequence. However,
little is known about the role of APC gene mutations in this
alternative pathway. Therefore, we investigated APC and K-ras
mutations in colorectal tumours, focussing especially on the
morphology and stage of these tumours.
MATERIALS AND METHODS
Tissues
Formalin-fixed, paraffin-embedded tissue samples of 63 colorectal
adenomas and 100 invasive colorectal carcinomas, resected opera-
tively or endoscopically from 1988 to 1998, were examined. All
studied adenomas were classified as either mild atypia or moderate
atypia. Tumours with high-grade atypia were excluded from this
study to standardize the background. Cases with familial adeno-
matous polyposis (FAP) or hereditary non-polyposis colorectal
cancer (HNPCC), meeting the criteria established by the
International Collaborative Group on HNPCC (Vasen et al, 1991),
were excluded.
Morphological classification
Haematoxylin and eosin (H&E)-stained sections of each tumour
were carefully examined by the same two pathologists (TM and
KM) independently to confirm the diagnosis and morphological
classification. Sixty-three adenomas were classified as 31 poly-
poid adenomas and 32 superficial adenomas, and the latter were
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Correspondence to: N Umetanisubclassified as 17 superficial elevated adenomas and 15 superfi-
cial depressed adenomas according to their morphological features
(Japanese Research Society for Cancer of the Colon and Rectum,
1983), as described below. A superficial adenoma is a lesion
whose height above the muscularis mucosa is less than twice that
of the surrounding normal mucosa. A superficial depressed
adenoma is a lesion whose height above the muscularis mucosa is
less than that of the surrounding normal mucosa in more than 50%
of tumour basal area, and the remainder were superficial elevated
adenomas. Typical histologic appearances of superficial adenomas
are shown in Figure 1. Sixty-six sm carcinomas were classified
as 47 polypoid carcinomas and 19 non-polypoid carcinomas
according to their morphological features, as described below. A
polypoid carcinoma grows with a polypoid margin overhanging
the surrounding normal mucosa. A non-polypoid carcinoma has
central ulceration and a non-polypoid margin, encircled by normal
mucosa at the periphery. Typical histologic appearances are shown
in Figure 2. Six specimens of sm carcinomas that could not be
definitively classified were excluded from this study. Thirty-four
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Table 1 Morphological classification of examined tumours and sample number, co-existence of adenomatous component, K-ras codon 12 point mutation,
and APC mutation in mutation cluster region
Morphological Number Adenomatous
Deptha classification of tumours componentb K-rasc APCd
Adenoma Polypoid 31 – 9/29 (31%)f 13/30 (43%)h
Superficial elevated 17 – 5/17 (29%) 3/16 (19%)
Superficial depressed 15 – 0/15 (0%) 1/15 (7%)
Carcinoma sm Polypoid 47 49%e 24/43 (56%)g 20/47 (43%)
Non-polypoid 19 0% 2/19 (11%) 6/17 (35%)
mp 34 18/30 (60%) 14/33 (42%)
Total 163
asm: carcinomas invading into the submucosal layer; mp: carcinomas invading into the muscularis propria. bCo-existence ratio of adenomatous component.
cFrequency of K-ras codon 12 mutation. dFrequency of APC mutation in mutation cluster region. eP < 0.0001, polypoid sm carcinoma vs. non-polypoid sm
carcinoma by Fisher’s exact test. fP = 0.018, polypoid adenoma vs. superficial depressed adenoma by Fisher’s exact test. gP = 0.0008, polypoid
sm carcinoma vs. non-polypoid sm carcinoma by Fisher’s exact test. hP = 0.016, polypoid adenoma vs. superficial depressed adenoma by Fisher’s exact test.
A
B
Figure 1 Typical histologic appearances of a superficial elevated adenoma
and a superficial depressed adenoma. A superficial adenoma is a lesion
whose height above the muscularis mucosa is less than twice that of the
surrounding normal mucosa. A superficial depressed adenoma is a lesion
whose height above the muscularis mucosa is less than that of the
surrounding normal mucosa in more than 50% of tumour basal area and the
remainder are superficial elevated adenomas. (A) A typical superficial
elevated adenoma. (B) A typical superficial depressed adenoma.
A
B
Figure 2 Typical histologic appearances of a polypoid carcinoma and a
non-polypoid carcinoma. A polypoid carcinoma grows with a polypoid margin
overhanging the surrounding normal mucosa. A non-polypoid carcinoma has
central ulceration and a non-polypoid margin, encircled by normal mucosa at
the periphery. (A) A typical polypoid carcinoma. (B) A typical non-polypoid
carcinomaadvanced carcinomas showed invasion into the muscularis propria
(mp carcinomas) (Table 1). Advanced carcinomas were not
subclassified.
DNA extraction
Several 20-mm sections were obtained from the paraffin-embedded
blocks, and neoplastic lesions were precisely dissected under
microscopy with reference to the adjacent H&E-stained section.
Contamination of normal tissue was limited to interstitial cells,
and most normal epithelial cells were excluded from the speci-
mens. DNA was extracted from each specimen after deparaffiniza-
tion by treatment with sodium dodecyl sulphate (SDS)-proteinase
K and phenol–chloroform–isoamyl alcohol as described previ-
ously (Goeltz et al, 1985). The DNA concentration was adjusted to
20 ng ml–1.
Detection of K-ras codon 12 point mutations
K-ras mutations were examined focusing on codon 12, because
K-ras mutations in sporadic colorectal tumours occur predomi-
nantly (77–82%) at this codon (Bos et al, 1987; Oudejans et al,
1991). The DNA was amplified and analysed by two-step poly-
merase chain reaction (PCR)-restriction fragment length polymor-
phism (RFLP) according to a previously described method
(Figure 3) (Levi et al, 1991; Yamagata et al, 1994). Negative and
positive controls (wild-type DNA and mutated DNA) were run
with each analysis. Since this method had enough high sensitivity,
contamination of normal cells did not influence the result.
Detection of APC MCR mutations
The APC area searched for mutations was restricted to the muta-
tion cluster region (MCR) in which more than 80% of sporadic
colorectal carcinomas harbour mutations (Miyoshi et al, 1992;
Be’roud et al, 1996). We searched for APC mutations by PCR-
single strand conformation polymorphism (SSCP) and direct
sequencing methods. Five sets of overlapping PCR primers were
synthesized to amplify exon 15 codons 1251–1536 including the
whole MCR. The lengths of the five amplified fragments were in
the range of 194–227 bases.
The primers used for PCR were as follows: MCR1F (forward):
5¢-AAGGCTGCCACTTGCAAAG-3¢; MCR1R (reverse):
5¢-CTTCAGCTGACCTAGTTCC-3¢; MCR2F (forward):
5¢-GCTAATACCCTGCAAATAGC-3¢; MCR2R (reverse):
5¢-GGTGTCTGAGCACCACTTT-3¢; MCR3F (forward):
5¢-TTCTTCAGGAGCGAAATCTC-3¢; MCR3R (reverse):
5¢-GGGCTATCTGGAAGATCAC-3¢; MCR4F (forward):
5¢-CAGTGGAATGGTAAGTGGC-3¢; MCR4R (reverse):
5¢-AGCATCTGGAAGAACCTGG-3¢; MCR5F (forward):
5¢-GAGTGGACCTAAGCAAGCT-3¢; MCR5R (reverse):
5¢-TCCTGAACTGGAGGCATTAT-3¢.
We screened all fragments for mutations by SSCP, and then
determined the sequences of fragments that showed aberrant bands
by the direct sequencing method. In SSCP, the DNA was amplified
using a thermal cycler (Perkin-Elmer PCR9600) in 5-ml reaction
mixtures containing 20-ng extracted tissue DNA, 0.1 pM each set
of primers labelled with 32P-ATP, 200 mM deoxyribonucleoside
triphosphates, 0.125 unit Taq polymerase (Perkin-Elmer(R)
AmpliTaqGold), and a 10% volume of attached buffer according
to the following protocol: 10 min at 95°C for polymerase activa-
tion, 40 cycles at 94°C for 30 s, 55°C for 2 min, 72°C for 1 min,
followed by an additional 3 min at 72°C. The PCR products were
electrophoresed on 5% acrylamide gels containing 6% glycerol at
4°C for 3 h at 1600 volts. The gels were dried and exposed to
X-ray film. The fragments that showed aberrant migration patterns
on SSCP were directly sequenced employing an Amersham
Sequenase Version 2.0 7-deaza-dGTP kit with 35S-dCTP, following
the manufacturer’s protocol with the internal primers described
below.
The internal sequencing primers used for direct sequencing
were as follows: M CR1intF (forward): 5¢-GCCACTTG-
CAAAGTTTCTTCT-3¢; MCR1intR (reverse): 5¢-CAGCTGACC-
TAGTTCCAATC-3¢; MCR2intF (forward): 5¢-TACCCTG-
CAAAT AGCAGAAATA-3¢; MCR2intR (reverse): 5¢-TCTGAG-
CACCACTTTTGGAG-3¢; M CR3intF (forward): 5¢-AGGAGC-
GAAATCTCCCTCC-3¢; MCR3intR (reverse): 5¢-T ATCTG-
GAAGATCACTGGGG-3¢; MCR4intF (forward): 5¢-GGAATG-
GTAAGTGG CATTATAA-3¢; MCR4intR (reverse): 5¢-CTGGA-
AGAACCTGGACCCT-3¢; MCR5i ntF (forward): 5¢-GACC-
TAAGCAAGCTGCAGTA-3¢; MCR5intR (reverse): 5¢-GA
ACTG-GAGGCATTATTCTTAA-3¢.
Single-stranded template DNA for sequencing was prepared by
asymmetric PCR (Gyllensten et al, 1988) with some modifica-
tions. All of the mutations detected were confirmed in the other
direction and by performing the experiments at least twice
APC, K-ras in colorectal tumorigenesis 11
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Figure 3 Detection of K-ras codon 12 point mutations by two-step
PCR-RFLP method. N: Normal control. P: Positive control. The arrow
indicates the MVA-I digestion site in the second PCR product of wild-type
allele, dividing the 106 base pair product into two fragments of 77 and
29 base pairs
G A T C G A T C C T A G G A T C
‘A’ insertion at codon 1406
Normal Carcinoma
Non-sense mutation at codon 1453
Forward Reverse
Figure 4 Detection of mutations in APC MCR using direct sequencing
method. (A) Arrowhead indicates ‘A’ insertion at codon 1406. (B) Arrowhead
indicates ‘C’ to ‘T’ nucleotide change (Glu to Stop) at codon 1453, resulting in
truncated protein12 N Umetani et al
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Table 2 APC somatic mutations in exon 15 codons 1251 to 1536 including MCR
Size Morphological
Case Histology (mm) Depthb classification Codon Nucleotide change Mutation effect
Adenomas
A2 Mild 25 Polypoid 1286 G insertion Frame-shift
A7 Mild 18 Polypoid 1303 TT deletion Frame-shift
A9 Mild 13 Polypoid 1408 CC deletion Frame-shift
A12 Mod. 5 Polypoid 1282 C to G (ser to Stop) Non-sense
A13 Mild 7 Polypoid 1340 C deletion Frame-shift
A22 Mild 7 Polypoid 1384 CA deletion Frame-shift
A29 Mild 8 Polypoid 1313 C insertion Frame-shift
AH2 Mild 19 Polypoid 1451 A deletion Frame-shift
AH17 Mild 12 Polypoid 1376 C deletion Frame-shift
AH21 Mod. 6 Polypoid 1315 GAAAA deletion Frame-shift
AH22 Mild 6 Polypoid 1378 G insertion Frame-shift
AH23 Mild 9 Polypoid 1362 T deletion Frame-shift
AH28 Mild 7 Polypoid 1379 C to A (Pro to Thr) Amino acid change
FA7 Mild 2 Superficial Elevated 1384 CA deletion Frame-shift
FA10 Mild 4 Superficial Elevated 1394 T deletion Frame-shift
FA18 Mild to mod. 5 Superficial Elevated 1414 G to A (Gly to Gln) Amino acid change
FA15 Mild 4 Superficial Depressed 1464 G insertion Frame-shift
Invasive carcinomas
SO4 Well 14 sm Polypoid 1417 A insertion Frame-shift
SO6 Well 20 sm Polypoid 1359 A to T(Glu to Val) Amino acid change
SO8 Well 5 sm Polypoid 1415 A insertion Frame-shift
SO17 Well 17 sm Polypoid 1406 A insertion Frame-shift
SR4 Well 20 sm Polypoid 1497 T insertion Frame-shift
SR7 Well 9 sm Polypoid 1470 G to T (Glu to Stop) Non-sense
SR9 Well 13 sm Polypoid 1470 G to T (Glu to Stop) Non-sense
SR13 Well 20 sm Polypoid 1309 C to T (Gln to Stop) Non-sense
SR17 Well 83 sm Polypoid 1470 G to T(Glu to Stop) Non-sense
SE2 Well 13 sm Polypoid 1384 G deletion Frame-shift
SE6 Well 12 sm Polypoid 1373 T insertion Frame-shift
SE8 Well 15 sm Polypoid 1407 T deletion Frame-shift
SE10 Well 9 sm Polypoid 1275 TA deletion Frame-shift
SE11 Well 8 sm Polypoid 1397 A insertion Frame-shift
SE15 Well 5 sm Polypoid 1295 A deletion Frame-shift
ST11 Well 10 sm Polypoid 1317 TGGAA deletion Frame-shift
ST16 Well 30 sm Polypoid 1424 AA deletion Frame-shift
ST22 Well 30 sm Polypoid 1309 C to T (Gln to Stop) Non-sense
ST34 Well 12 sm Polypoid 1427 A deletion Frame-shift
ST35 Mod. 18 sm Polypoid 1297 GCAGAA deletion Frame-shift
SR12 Well 3 sm non-Polypoid 1327 CGAAG deletion Frame-shift
SO43 Well 7 sm non-Polypoid 1422 T insertion Frame-shift
SO5 Well 14 sm non-Polypoid 1542 G insertion Frame-shift
SE9 Well 9 sm non-Polypoid 1399 T to C (Leu to Pro) Amino acid change
ST5 Well 20 sm non-Polypoid 1314 C insertion Frame-shift
P1 Well 27 mp 1453 C to T (Glu to Stop) Non-sense
P8 Mod. 45 mp 1515 T insertion Frame-shift
P9 Mod 24 mp 1416 G to A (Glu to Lys) Amino acid change
P11 Well 30 mp 1374 A insertion Frame-shift
P12 Muc. 17 mp 1329 A insertion Frame-shift
P13 Por. 50 mp 1420 A deletion Frame-shift
P15 Well 24 mp 1375 C deletion Frame-shift
P17 Well 45 mp 1395 T deletion Frame-shift
P18 Well 32 mp 1318 GAACT deletion Frame-shift
P19 Well 43 mp 1307 C deletion Frame-shift
P20 Well 23 mp 1328 G insertion Frame-shift
P21 Well 18 mp 1385 TA deletion Frame-shift
P44 Well 34 mp 1340 CC deletion Frame-shift
P47 Well 21 mp 1493 TTTA deletion Frame-shift
aFor adenomas: mild: mild atypia; mod.: moderate atypia. For carcinomas: well: well differentiated adenocarcinoma; mod.: moderately differentiated
adenocarcinoma; por.: poorly differentiated adenocarcinoma; muc: mucinous adenocarcinoma. bsm: carcinomas invading into the submucosal layer;
mp: carcinomas invading into the muscularis propria.(Figure 4). To distinguish and exclude mutations resulting in
amino acid replacements from polymorphism, we determined the
sequence of DNA obtained from normal tissue of the same patient
(data not shown).
Statistical analysis
All of the P-values were calculated by Fisher’s exact test.
According to Bonferroni’s inequality, P-values smaller than 0.025
are statistically significant on multiple comparisons.
RESULTS
Tumour morphology and histology
Most of the sm carcinomas were well differentiated carcinomas
(52/61, 85%), and the remaining ones were moderately differenti-
ated carcinomas. The percentage of each histological type was
identical between polypoid carcinomas and non-polypoid carci-
nomas (polypoid: well 87%, mod, 13%; non-polypoid: well 84%,
mod, 16%). As shown in Table 1, 49% of polypoid carcinomas
contained an adenomatous component, however, none of non-
polypoid carcinomas did. There was a statistically significant
difference in the frequency of adenomatous components between
polypoid carcinomas and non-polypoid carcinomas (P < 0.0001).
K-ras mutations
As shown in Table 1, K-ras mutations at codon 12 were present in
nine of 29 (31%) polypoid adenomas, five of 17 (29%) superficial
elevated adenomas and none of 15 (0%) superficial depressed
adenomas. The frequency of mutation in superficial depressed
adenomas was significantly lower than that in polypoid adenomas
(0% vs 31%: P = 0.018). The frequency of mutation in non-
polypoid carcinomas was significantly lower than that in polypoid
carcinomas (11% vs 56%: P = 0.0008), and was relatively low
compared with that in polypoid adenomas (11% vs 31%).
APC mutations
Among 56 mutations detected in APC MCR, 51 (91%) were
frame-shift or non-sense mutations resulting in truncated proteins,
and the remaining five (9%) were one base replacements resulting
in single amino acid changes (Table 2). As shown in Table 1, APC
mutations were found in 13 of 30 (43%) polypoid adenomas, three
of 16 (19%) superficial elevated adenomas, one of 15 (7%) super-
ficial depressed adenomas, 20 of 47 (43%) polypoid carcinomas,
six of 17 (35%) non-polypoid carcinomas and 14 of 33 (42%)
advanced carcinomas. Polypoid adenomas, polypoid carcinomas
and advanced carcinomas showed almost the same frequency of
APC mutation. The frequency of APC mutation in superficial
depressed adenomas was significantly lower than that in polypoid
adenomas (7% vs 43%: P = 0.016). The frequency of APC muta-
tion in polypoid carcinomas was similar to that in non-polypoid
carcinomas, with no significant difference between them.
Relation between APC and K-ras mutations
As shown in Table 3, no correlation was observed between APC
mutations and K-ras mutations at any tumour stage.
DISCUSSION
To investigate the involvement of APC and K-ras mutations in
colorectal tumorigenesis, we collected colorectal tumours from
every morphological classification at every stage in the pathway.
We could collect only 15 superficial depressed adenomas because
they were very rare and it was rather difficult to find them. Other
types of adenomas and carcinomas were collected randomly
within the same period. The proportion of superficial depressed
adenomas examined in this study was higher than that expected
from the natural distribution.
Shimoda et al have conducted a pioneering study focusing on
the morphology of early colorectal carcinomas, in which these
carcinomas were classified into polypoid growth carcinomas,
based on intramucosal proliferation of adenoma and carcinoma,
and non-polypoid growth carcinomas without intramucosal protu-
berant growth (Shimoda et al, 1989).
We classified sm carcinomas into polypoid carcinomas and non-
polypoid carcinomas. This classification is relevant and easily
applicable to all early colorectal carcinomas including mucosal
carcinomas, because only peripheral overhanging of the tumour is
taken into consideration. This classification seems somewhat
subjective, but most tumours (66 out of 72) were definitely classi-
fied with no discrepancy. In this study, the significant difference
between polypoid carcinomas and non-polypoid carcinomas in the
frequency of existence of adenomatous components strongly
supports that this classification is suitable for the investigation of
colorectal tumorigenesis. There was no correlation between
morphological and histological classification. In consideration of
morphology, it can be assumed that polypoid carcinomas mainly
developed from polypoid adenomas through the conventional
adenoma–carcinoma sequence and that non-polypoid carcinomas
developed de novo or from superficial depressed adenomas
without demonstrating any substantial morphological changes.
Superficial elevated adenomas seemed to be intermediate lesions
of polypoid adenomas and superficial depressed adenomas.
As Vogelstein et al suggested, K-ras mutation is assumed to be
an early event in the adenoma–carcinoma sequence, contributing
APC, K-ras in colorectal tumorigenesis 13
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Table 3 Correlation between mutations of APC MCR and K-ras codon 12
Morphological K-rasa APCb
classification + –
Adenomas Polypoid + 2 5
–9 1 1N S c
Superficial elevated + 1 4
–29N S
Superficial depressed + 0 0
– 1 13 NS
(Total) + 3 9
–1 23 3 N S
sm ca. Polypoid + 12 12
– 6 12 NS
non-Polypoid + 0 2
–58N S
(Total) + 12 14
–1 1 2 0 N S
mp ca. + 6 11
–57N S
aK-ras codon 12 mutation; +: positive for mutation; –: negative for mutation.
bAPC mutation in mutation cluster region; +: positive for mutation; –: negative
for mutation. cNS: not significant.to growth and dysplastic change in adenoma development
(Vogelstein et al, 1988). However, they did not pay consideration
to superficial adenomas or special types of carcinoma such as non-
polypoid carcinoma. Therefore, we designed this study and found
that the frequency of K-ras mutation in non-polypoid carcinomas
was significantly lower than that in polypoid carcinomas, and that
it was lower than that in polypoid adenomas. Furthermore, we
demonstrated that the frequency of K-ras mutation in superficial
depressed adenomas was significantly lower than that in polypoid
adenomas. These results support the possibility that the precursors
of non-polypoid carcinomas are not polypoid adenomas, but are
de novo or superficial depressed adenomas, and non-polypoid
carcinomas do not progress through the conventional
adenoma–carcinoma sequence. This hypothesis fits the assump-
tion that polypoid adenomas do not progress into non-polypoid
carcinomas without bold morphological changes. K-ras mutations
do not appear to be requisite for the development of these tumours.
In this study, we also searched for APC mutations and demon-
strated that polypoid adenomas, polypoid carcinomas and
advanced carcinomas have almost the same frequency and distrib-
ution pattern of APC mutations. This result is compatible with the
concept that APC acts as the ‘gatekeeper’ of colonic epithelial cell
proliferation. The frequency of APC mutation in our study is
apparently lower than those reported previously (Kinzler et al,
1996). This may be because we searched for mutations only in
MCR, and the SSCP method used for screening has limited detec-
tion capability. This limitation was mainly due to the quantity and
quality of obtained DNA. Furthermore, we demonstrated for the
first time that the frequency of APC mutation in polypoid carci-
nomas was similar to that in non-polypoid carcinomas, which
indicates that the APC mutation is requisite for carcinomatous
development through the non-polypoid pathway. Supposing that
superficial depressed adenomas develop into non-polypoid carci-
nomas, the finding of a low frequency of APC mutation in super-
ficial depressed adenomas supports the hypothesis that new APC
mutations are acquired during carcinomatous change. To confirm
that this hypothesis is correct, accumulation of clinical observa-
tions and further investigation are required. Additionally, the
authors found no correlation between APC mutations in MCR and
K-ras mutations at codon 12 at any tumour stage, raising the possi-
bility that APC and K-ras gene mutations occur independently in
colorectal tumorigenesis.
In this study, we could not exclude the possibility that the differ-
ence of tumour size in each classification influenced the result.
However, since the difference of tumour size is an essential
element determining the morphological type, and the objective of
the present study is based on this, we consider that it is impossible
to exclude the influence of tumour size completely.
In this study the mutation of APC might have been masked by
DNA from contaminated normal cells, and therefore the frequency
of mutation might have been evaluated to be as falsely low. But the
quantity of contaminated normal DNA was considered to be not
enough to mask the mutations, and was assumed to be constant in
each classification, because we precisely cut out the neoplastic
lesions by the microdissection method and eliminated contamina-
tion with normal cells. Therefore we considered that the influence
on the result would be averaged and would thus be negligible.
There was no somatic APC mutations at two of the most
common sites: 5 bp deletion at codon 1309, and non-sense muta-
tion at codon 1450 (Miyaki et al, 1995), but we could not find any
explicable reason.
Because the number of investigated superficial depressed
adenomas was small, it is necessary to collect more specimens to
obtain a concrete conclusion. To confirm the different mechanism
between the conventional adenoma–carcinoma sequence and non-
polypoid pathway, we are conducting further studies focussing on
the clinical and genetic characteristics of superficial colorectal
lesions.
In summary, we conclude that there may be some pathway other
than the conventional adenoma–carcinoma sequence in develop-
ment of non-polypoid carcinomas. The precursors of most non-
polypoid carcinomas are considered to be not polypoid adenomas,
but de novo or superficial depressed adenomas. For carcinomatous
development through this non-polypoid pathway, APC mutation
seems to be requisite, but K-ras mutation not. It is possible that
new APC mutations are acquired after the development of super-
ficial depressed adenomas.
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